Pharmaceutical composition for treating neuropathic pain

A composition and neurological technology, applied in drug combination, neurological diseases, pharmaceutical formulations, etc., can solve problems such as adverse reactions and achieve significant curative effect

Inactive Publication Date: 2015-04-22
JINAN XINGYI MEDICAL TECH
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Anticonvulsants, opioids, and antidepressants are often used for treatment, but most products are not specific for neuropathic pain, and most of them are ineffective or only moderately relieve pain for most patients, and can cause adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1: Pharmaceutical composition for treating neuropathic pain

[0020] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0021] 20 parts by weight of morin, 25 parts by weight of polygala saponin A, 10 parts by weight of syringin, and 15 parts by weight of aucubin.

Embodiment 2

[0022] Example 2: Pharmaceutical composition for treating neuropathic pain

[0023] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0024] 30 parts by weight of morin, 15 parts by weight of polygala saponin A, 20 parts by weight of syringin, and 5 parts by weight of aucubin.

Embodiment 3

[0025] Example 3: Pharmaceutical composition for treating neuropathic pain

[0026] The composition and parts by weight of the bulk drug of the pharmaceutical composition for the treatment of neuropathic pain are:

[0027] 25 parts by weight of morin, 20 parts by weight of polygala saponin A, 17 parts by weight of syringin, and 10 parts by weight of aucubin.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating neuropathic pain, which is prepared by proportionally mixing crude drugs including morin, onjisaponin A, syringopicroside and aucubin. The pharmaceutical composition can be prepared in various forms according to conventional preparation technologies. The invention overcomes the defects in the prior art and provides the pharmaceutical composition which is effective and safe in treating neuropathic pain. The pharmaceutical composition provided by the invention is simple in preparation method and low in cost. Clinical tests prove that the pharmaceutical composition has remarkable clinical effects on treating neuropathic pain such as prosopalgia, ischialgia, radiculalgia, post-herpetic neuralgia and diabetic peripheral neuritis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a pharmaceutical composition for treating neuropathic pain. Background technique [0002] Neuropathic pain refers to pain syndromes caused by primary lesions or dysfunctions of the central or peripheral nervous system. It can be caused by trauma or / and disease-induced damage to peripheral nerves, posterior roots of the spinal cord, spinal cord and some parts of the central nervous system above. According to the etiology, nature and degree of nerve injury, it is clinically divided into two categories: central nerve pain and peripheral nerve pain caused by peripheral nerve injury. Central nerve pain, referred to as central pain, is primary pain caused by damage or dysfunction of the pain conduction pathway of the central nervous system. It is commonly seen in spinal cord trauma or cerebrovascular diseases, multiple sclerosis and tumors. Peripheral nerve pain is caused...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P25/02A61P25/04A61P3/10A61K31/352A61K31/704
Inventor 孔倩倩史国玉
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap